Inhibitor Therapeutics (INTI) Notes Payables (2013 - 2022)
Inhibitor Therapeutics' (INTI) quarterly Notes Payables came in at $411000.0 in Q4 2022, up 77.92% YoY from $231000.0 in Q4 2021, and little changed on a QoQ basis from $411000.0 in Q3 2022.
Inhibitor Therapeutics (INTI) Notes Payables (2013 - 2022) Analysis & Trends
Inhibitor Therapeutics (INTI) has 5 years of Notes Payables data on file, last reported at $411000.0 in Q4 2022.
- Quarterly Notes Payables rose 77.92% year-over-year to $411000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $411000.0 (up 77.92% YoY) and the FY2022 annual result came in at $411000.0, up 77.92% from the prior year.
- Notes Payables was little changed at $411000.0 in Q4 2022, from $411000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $411000.0 in Q3 2022 to a low of $16178.0 in Q2 2020.
- A 3-year average of $216791.6 and a median of $256000.0 in 2021 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2021 — Notes Payables surged 668.87% — and 2022, when it jumped 77.92%.
- Tracing INTI's Notes Payables over 3 years: stood at $30044.0 in 2020, then surged by 668.87% to $231000.0 in 2021, then jumped by 77.92% to $411000.0 in 2022.
- The last three Notes Payables figures came in at $411000.0 (Q4 2022), $411000.0 (Q3 2022), and $331000.0 (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Inhibitor Therapeutics | 15.64 Mn | 15.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 411,000.00 |
| Sep 30, 2022 | 411,000.00 |
| Jun 30, 2022 | 331,000.00 |
| Mar 31, 2022 | 281,000.00 |
| Dec 31, 2021 | 231,000.00 |
| Dec 31, 2020 | 30,044.00 |
| Sep 30, 2020 | 23,111.00 |
| Jun 30, 2020 | 16,178.00 |
| Sep 30, 2014 | 41,920.00 |
| Jun 30, 2014 | 102,420.00 |
| Mar 31, 2014 | 77,701.00 |
| Dec 31, 2013 | 68,428.00 |
| Sep 30, 2013 | 68,428.00 |